Hindustan Bio Sciences (BOM:532041) Cash-to-Debt : N/A (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hindustan Bio Sciences's cash to debt ratio for the quarter that ended in Dec. 2023 was N/A.

The historical rank and industry rank for Hindustan Bio Sciences's Cash-to-Debt or its related term are showing as below:

During the past 13 years, Hindustan Bio Sciences's highest Cash to Debt Ratio was 0.26. The lowest was 0.00. And the median was 0.02.

BOM:532041's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.93
* Ranked among companies with meaningful Cash-to-Debt only.

Hindustan Bio Sciences Cash-to-Debt Historical Data

The historical data trend for Hindustan Bio Sciences's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Hindustan Bio Sciences Cash-to-Debt Chart

Hindustan Bio Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash-to-Debt

Get a 7-Day Free Trial

0.05

0.08

0.01

Hindustan Bio Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															-	N/A	-	-	N/A

Competitive Comparison of Hindustan Bio Sciences's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hindustan Bio Sciences's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Cash-to-Debt falls into.

Hindustan Bio Sciences Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Hindustan Bio Sciences's Cash to Debt Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.095	/	(13.335	+	11.219)
	=	0.00

Hindustan Bio Sciences's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Hindustan Bio Sciences (BOM:532041) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Hindustan Bio Sciences Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Hindustan Bio Sciences (BOM:532041) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034

Website

https://www.hindustanbiosciences.in

Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines